Tag

Nanoviricides

All articles tagged with #nanoviricides

health2 years ago•3 min saved

"Exploring the Lucrative Market for Treating Widespread Lung Infections with Over 200,000 Annual Hospitalizations"

The market for therapeutics for Respiratory Syncytial Virus (RSV), a common and highly contagious lung infection, is projected to reach $8.73 billion by 2031. Currently, there are limited treatment options available, with the toxic drug ribavirin being used as a last resort for severe cases. NanoViricides, a leading developer of antiviral treatments, is developing a safe and effective alternative therapeutic called NV-387, which has shown promising results in pre-clinical animal studies. The drug is currently in phase 1 human clinical trials and has been found to be safe with no side effects reported so far. If successful, NV-387 could revolutionize the treatment of RSV infections.

via Benzinga|

#health #lung-infection #nanoviricides

health2 years ago•3 min saved

Unveiling the Safest Treatment Option for SARS-CoV-2: Promising Clinical Trials and Discoveries

NanoViricides has initiated clinical trials for its drug NV-CoV-2, which aims to provide a safer and more comprehensive treatment for COVID-19. The drug, developed by NanoViricides, has shown a robust safety profile in pre-clinical evaluations and is designed to eliminate the virus from the patient's system. It is being trialed on patients with mild to moderate COVID-19, with potential efficacy for severe cases and hospitalized patients. NV-CoV-2 has been shown to be more effective than Remdesivir in animal models. The drug's multiple formulations, including oral and injectable options, make it suitable for various patient populations. NanoViricides believes that the safety and efficacy of NV-CoV-2 could make it a popular choice in the market.

via Benzinga|

#clinical-trials #covid-19 #health